Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery
- PMID: 35959618
- DOI: 10.2174/1574887117666220811143426
Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery
Abstract
Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and disabling diseases that affect the gastrointestinal tract. This relapsing course is often unpredictable with severe flares and the need for intensive medical treatment, hospitalization, or emergent/urgent surgery, all of which significantly impact patients' quality of life (QoL). QoL in IBD patients is significantly lower than in the general population, and depression and anxiety have been shown to have a higher prevalence than in healthy individuals, especially during disease flares. Complications requiring hospitalization and repeated surgeries are not uncommon during the disease course and significantly affect QoL in IBD patients. Patient-reported outcome measures (PROMs) can be used to measure the impact of chronic disease on QoL from the patient's perspective. The use of PROMs in IBD patients undergoing surgery could help to investigate the impact of the surgical procedure on QoL and determine whether there is any improvement or worsening. This review summarizes the use of PROMs to assess QoL after various surgical procedures required for IBD treatment.
Keywords: Quality of life; crohn’s disease; inflammatory bowel disease; outcome measure; patient reported; psychological distress; ulcerative colitis.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients.Am J Clin Nutr. 2021 Apr 6;113(4):832-844. doi: 10.1093/ajcn/nqaa395. Am J Clin Nutr. 2021. PMID: 33677550
-
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study.Aliment Pharmacol Ther. 2022 Jan;55(2):201-211. doi: 10.1111/apt.16616. Epub 2021 Sep 29. Aliment Pharmacol Ther. 2022. PMID: 34587655
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294382 Free PMC article.
-
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.Expert Rev Gastroenterol Hepatol. 2021 Sep;15(9):985-997. doi: 10.1080/17474124.2021.1911644. Epub 2021 Jun 15. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34130572
-
Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment.Nat Rev Gastroenterol Hepatol. 2022 Nov;19(11):717-726. doi: 10.1038/s41575-022-00634-6. Epub 2022 Jun 22. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35732730 Review.
Cited by
-
Saffron as a Promising Therapy for Inflammatory Bowel Disease.Nutrients. 2024 Jul 20;16(14):2353. doi: 10.3390/nu16142353. Nutrients. 2024. PMID: 39064796 Free PMC article. Review.
-
Surgical treatment of inflammatory bowel disease: From the gastroenterologist's stand-point.World J Gastrointest Surg. 2024 May 27;16(5):1235-1254. doi: 10.4240/wjgs.v16.i5.1235. World J Gastrointest Surg. 2024. PMID: 38817292 Free PMC article.
References
-
- Levine JS,; Burakoff R.; Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011,7(4),235-41 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical